Depression symptoms of African American patients with cancer under-recognized
the ONA take:
Depression symptoms of African American patients with cancer are often under-recognized, a new study by researchers at Case Western Reserve University in Cleveland, Ohio, has found.
For the study, researchers sought to investigate whether depression in African American patients with cancer goes under-recognized for treatment.
The researchers identified 34 depressed African American cancer patients, 23 non-depressed African American cancer patients, and 17 depressed Caucasian cancer patients at a Northeast Ohio medical center.
All participants had been diagnosed with early-stage breast or prostate cancer within the last 3 years and received their last treatment at least 6 months ago. Patients were asked open-ended questions to assess their depression.
Results showed that depressed African American patients reported more irritability, wanting to be alone, insomnia, fatigue, and crying than non-depressed black patients.
Researchers also found that depressed black patients reported sad feelings less frequently than depressed white patients. Black patients were also more likely to use words like "feeling down," "low," "gloomy," or "blue" to describe their feeling rather than "depressed."
Depression symptoms of African American patients with cancer are often under-recognized.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Open Hysterectomy Survival Rates Edge Minimally Invasive Procedures for Cervical Cancer
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|